Trial intelligence / Profile preview

Oral Lactulose for Postoperative Gastrointestinal Recovery After Complex Appendectomy

NCT07589465Recruiting

Sponsor
Nanchong City Central Hospital
Start
Jun 2026
Primary completion
Jun 2029
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Randomised, triple-blind trial in postoperative ileus (POI) comparing Lactulose Group with Placebo Group (2 arms). Primary endpoint: Time to GI-2. Started Jun 2026; status: recruiting.

02

Drugs

lactulose
03

Conditions

postoperative ileus (POI)

Beyond the preview

Go deeper on NCT07589465.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07589465.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call